In late 2007, and in the face of a high imprisonment rate and unmitigated growth in the prison population over the past decade, Scotland’s Cabinet Secretary for Justice launched an independent...
ARCADE: A Cooperative Research Project on Parallel Text Alignment Evaluation (1998)
Phillippe Langlais, Langlais Ph, Jean Veronis, S. Armstrong, P. Bonhomme, F. Debili, ...
This paper describes the work achieved in the first half of a 4-year cooperative research project (ARCADE), financed by AUPELF-UREF. The project is devoted to the evaluation of parallel text...
The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy (1997)
Crawford, J., Kreisman, H., Garewal, H., Jones, S. E., Shoemaker, D., Pupa, M. R., ...
Background A phase 2 trial was done to study effects of varying treatment schedule of Filgrastim (r-metHuG-CSF) on hematologic recovery following chemotherapy. Patients and methods Forty-six patients...
Cox, K, Wilson, E, Arthur, A, Elkan, R, Armstrong, S
The effect of a nurse-managed intervention, for early phase cancer trial participants at trial conclusion, on psychosocial outcomes was evaluated at two cancer centres in the Midlands, England using...
Lack of EGF receptor contributes to drug sensitivity of human germline cells
Park, S-J, Armstrong, S, Kim, C-H, Yu, M, Robertson, K, Kelley, M R, ...
Germline mutations have been associated with generation of various types of tumour. In this study, we investigated genetic alteration of germline tumours that affect the drug sensitivity of cells....
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy
Glaspy, J A, Jadeja, J S, Justice, G, Kessler, J, Richards, D, Schwartzberg, L, ...
In part A of this study, patients were randomised to cohorts receiving darbepoetin alfa at doses of 0.5 to 8.0 m.c.g. kg−1 wk−1 or to a control group receiving epoetin alfa at an initial...